Silence Therapeutics (SLN) Other Operating Expenses (2024 - 2026)
Silence Therapeutics (SLN) reported Other Operating Expenses of $4.75 million for the quarter ended Jun 30, 2026, down 61.2% from $12.23 million a year earlier but up 9.4% from the prior quarter.
Silence Therapeutics (SLN) Other Operating Expenses (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Silence Therapeutics' Other Operating Expenses came in at $27.06 million, down 51.4% year-over-year; for the year ended Dec 31, 2025, it came in at $44.87 million, up 4.6% from the prior year.
- Other Operating Expenses has increased for three consecutive years, with a three-year compound annual growth rate of 22.6% (years ended Dec 2022 to Dec 2025).
- By year, Other Operating Expenses came in at $42.9 million in the year ended Dec 31, 2024 (+22.4%), $35.05 million in the year ended Dec 31, 2023 (+44.1%) and $24.32 million in the year ended Dec 31, 2022.
- Five-year quarterly Other Operating Expenses spans a low of $4.34 million in the quarter ended Mar 31, 2026 and a high of $15.19 million in the quarter ended Dec 31, 2024.
- Year over year, Other Operating Expenses has now declined in each of the last four quarters, with an average decline of 2.2% over the last six quarters.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $4.34 million (quarter ended Mar 31, 2026), $4.82 million (quarter ended Dec 31, 2025) and $13.15 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Silence Therapeutics | 516.41 Mn | 444.31 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.75 Mn |
| Mar 31, 2026 | 4.34 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Sep 30, 2025 | 13.15 Mn |
| Jun 30, 2025 | 12.23 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Dec 31, 2024 | 15.19 Mn |
| Sep 30, 2024 | 13.64 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 6.30 Mn |
Silence Therapeutics Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();